People
Under the leadership of Dr. Daniel Vasella, the Novartis Executive Committee (ECN) is responsible for overseeing the business operations of Group companies. The ECN, whose members are chosen by the Board of Directors, consists of these senior executives:
Executive Committee
Daniel Vasella, M.D.
Chairman and CEO
Read biography:
Andreas Rummelt, Ph.D.
Group Head of Quality Assurance and Technical Operations
Read biography:
Joseph Jimenez
CEO Pharmaceuticals
Read biography:
Joerg Reinhardt, Ph.D.
COO of the Novartis Group
Read biography:
Juergen Brokatzky-Geiger, Ph.D.
Head of Human Resources
Read biography:
Mark C. Fishman, M.D.
President of the Novartis Institutes for Biomedical Research (NIBR)
Read biography:
Raymund Breu, Ph.D.
Chief Financial Officer
Read biography:
Thomas Wellauer, Ph.D.
Head of Corporate Affairs
Read biography:
Thomas Werlen, Ph.D.
General Counsel
Read biography:
Permanent Attendee of the Executive Committee
Andrin Oswald, M.D.
CEO Vaccines and Diagnostics
Read biography:
David Epstein
President and CEO Oncology and Molecular Diagnostics
Read biography:
George Gunn
CEO Consumer Health
President and CEO Animal Health
Read biography:
Jeffrey George
CEO Sandoz
Read biography:
Other members of Senior Management
Ann Bailey
Head of Corporate Communications
Read biography:
Bruno Heynen
Secretary to the Executive Committee
Monika Matti
Corporate Secretary
Paul Herrling, Ph.D.
Head of Corporate Research
Read biography:
Steven Barlow
Internal Audit
Our businesses
We offer a wide range of healthcare products in pharmaceuticals, vaccines and diagnostics, generics and consumer health.
Corporate governance
We are fully committed to good corporate governance.
Corporate structure
Download our organizational structure chart
(PDF 2.09MB)